Related Experiment Videos
[Parvovirus B19 infection: the general aspects and gestational problems]
L Di Stefano1, G Carta, R Barnabei
1Università degli Studi de L'Aquila, Clinica Ostetrica e Ginecologica, USSL N. 6.
Minerva Ginecologica
|April 1, 1995
Summary
Most pregnant women lack Parvovirus B19 antibodies, increasing infection risk. Early detection of IgG and IgM anti-B19 antibodies is crucial during pregnancy to prevent complications like intrauterine death.
Area of Science:
- Virology: Focuses on Parvovirus B19, a DNA virus.
- Immunology: Investigates antibody prevalence (IgM, IgG) in pregnant women.
Context:
- Parvovirus B19 causes erythema infectiosum (fifth disease) and can lead to serious complications.
- Diagnosis typically involves detecting virus-specific antibodies in serum.
- Pregnancy poses unique risks for Parvovirus B19 infection.
Purpose:
- To determine the prevalence of Parvovirus B19 infection in pregnant women.
- To assess the risk of infection among pregnant individuals lacking specific antibodies.
- To evaluate the utility of antibody detection for routine screening.
Summary:
- A study evaluated 87 pregnant patients for Parvovirus B19 antibodies.
- Results showed 64% of pregnant women lacked specific antibodies, indicating a high risk.
- One case of intrauterine death was linked to a patient with IgM antibodies.
Impact:
- Highlights a significant population at risk for Parvovirus B19 during pregnancy.
- Suggests routine screening for IgG and IgM anti-B19 antibodies in pregnant patients.
- Emphasizes the potential link between Parvovirus B19 and adverse pregnancy outcomes.